“METABOLIC AND CARDIOVASCULAR RISKS OF SECOND-GENERATION ANTIPSYCHOTICS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF WEIGHT GAIN, DYSLIPIDEMIA, HYPERGLYCEMIA, AND QTC PROLONGATION IN ADULTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER COMPARING OLANZAPINE, RISPERIDONE, QUETIAPINE, AND ARIPIPRAZOLE”. Frontier in Medical and Health Research 4, no. 3 (March 16, 2026): 599–610. Accessed November 8, 2026. https://fmhr.net/index.php/fmhr/article/view/2481.